logo

For the Inventor, By the Inventor

Chatenay Malabry, France

Antonio Almario Garcia

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Chantenay Malabry, FR (2005)
  • Chatenay Malabry, FR (2005 - 2012)
  • Paris, FR (2010 - 2014)

Company Filing History:

goldMedal13 out of 389 
 
Sanofi-Aventis
 patents
silverMedal5 out of 1,456 
 
Sanofi
 patents
bronzeMedal3 out of 73 
 
Mitsubishi Pharma Corporation
 patents
4. 1 out of 152 
 
Sanofi-Synthelabo
 patents
5. 1 out of 258 
 
Mitsubishi Tanabe Pharma Corporation
 patents
where one patent can have more than one assignee

Years Active: 2005-2014

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 8846676 - 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof (2014-09-30),
2. 8507520 - Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof (2013-08-13),
3. 8354405 - 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof (2013-01-15),
4. 8338451 - [object Object] (2012-12-25),
5. 8273758 - Substituted tricyclic derivatives (2012-09-25),
6. 8114866 - Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme (2012-02-14),
7. 8026258 - Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics (2011-09-27),
8. 7973042 - Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors (2011-07-05),
9. 7915284 - 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof (2011-03-29),
10. 7781590 - Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors (2010-08-24),
11. 7696374 - Arylalklcarbamate derivatives, preparation method thereof and use of same in therapeutics (2010-04-13),
12. 7687503 - Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme (2010-03-30),
13. 7674805 - Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics (2010-03-09),
14. 7632850 - Arylalkylcarbamate derivatives and production thereof (2009-12-15),
15. 7566720 - [object Object] (2009-07-28),

Title: Antonio Almario Garcia - Innovative Inventor from Chatenay Malabry

Introduction: Antonio Almario Garcia is a renowned inventor hailing from Chatenay Malabry, France, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Antonio Almario Garcia holds several patents in the areas of renewable energy, biotechnology, and artificial intelligence, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, Antonio Almario Garcia has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the industry. His passion for innovation and problem-solving has led to the creation of numerous groundbreaking inventions.

Collaborations: Antonio Almario Garcia has collaborated with top companies and inventors worldwide, fostering a culture of creativity and excellence in the field of technology. His collaborative efforts have resulted in the development of innovative solutions that have had a lasting impact on society.

Conclusion: Antonio Almario Garcia's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global technology landscape. His contributions continue to inspire future generations of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…